{
  "trial_id": "NCT03296930",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "chronic HCV infection",
      "label": "met",
      "evidence": "HCV RNA positive"
    },
    {
      "criterion": "age above 18 years",
      "label": "met",
      "evidence": "53-year-old man"
    },
    {
      "criterion": "male or female",
      "label": "met",
      "evidence": "alert male with no acute distress"
    },
    {
      "criterion": "normal kidney functions",
      "label": "met",
      "evidence": "Normal S.creatinine, Normal urine analysis, Normal renal sonography"
    }
  ],
  "exclusion": [
    {
      "criterion": "known renal disease",
      "label": "not_met",
      "evidence": "no evidence of lupus nephritis, diabetic nephropathy"
    },
    {
      "criterion": "abnormal kidney functions",
      "label": "not_met",
      "evidence": "Normal S.creatinine, Normal urine analysis, Normal renal sonography"
    }
  ],
  "notes": "Patient has been on IFN (100 mg/week) plus RBV (400 mg/day) combination therapy for the past 9 months and direct antiviral drugs were added to his treatment 6 months ago.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT03296930",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}